Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis. - Wikidata - wikimedia - TriplyDB

Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis.

Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis.

http://www.wikidata.org/entity/Q34547322

about

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.Use of highly active antiretroviral therapy in patients with renal insufficiency.Concise overview of the clinical pharmacokinetics of dideoxynucleoside antiretroviral agents.Management of antiretroviral drug therapy in human immunodeficiency virus infection.FHD: an index to evaluate drug elimination by hemodialysis.Pharmacokinetics, safety, and tolerability of ribavirin in hemodialysis-dependent patients.

P2860

Q34736194-184C6B6D-DC07-4971-90AC-60D054ACD5D0 Q34736674-CBDA50A7-277E-4049-A52C-7F14D9C03EB1 Q36130623-6F2041E6-53D7-47AC-8FB5-B226FCE3FD9A Q40552884-352F5325-1A7D-496A-9904-68126869234A Q40626125-F8E689F1-C780-49FA-802E-09811DF9BA40 Q46568505-EFBF67EF-5F18-40A8-AD8E-153B4918302C Q50554702-B203C589-F60B-4126-A7E9-1549E03C8795

P2860

Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis.

http://www.wikidata.org/entity/Q34547322

description

1992 nî lūn-bûn

@nan

1992 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1992 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

name

Didanosine pharmacokinetics in ...... on: influence of hemodialysis.

@ast

Didanosine pharmacokinetics in ...... on: influence of hemodialysis.

@en

Didanosine pharmacokinetics in ...... on: influence of hemodialysis.

@nl

type

label

Didanosine pharmacokinetics in ...... on: influence of hemodialysis.

@ast

Didanosine pharmacokinetics in ...... on: influence of hemodialysis.

@en

Didanosine pharmacokinetics in ...... on: influence of hemodialysis.

@nl

prefLabel

Didanosine pharmacokinetics in ...... on: influence of hemodialysis.

@ast

Didanosine pharmacokinetics in ...... on: influence of hemodialysis.

@en

Didanosine pharmacokinetics in ...... on: influence of hemodialysis.

@nl

P1433

Q34547322-CAB091C8-3F81-4B2C-AD53-6C2A6ED7918F

P1476

Q34547322-5F92A422-F29B-496F-99F7-361043991A91

P2093

Q34547322-125519F3-C062-4C90-B533-1AF651B4698B

Q34547322-14A74631-6C78-4171-AFD6-6E866F5A039C

Q34547322-33B2DD2E-E5E9-4126-A13A-BE2471BA83FB

Q34547322-33D9739C-4B65-45DC-A206-C9B780ACC664

Q34547322-6700C70A-D2F5-4BEB-BAAA-D6AC7A3C1745

Q34547322-75B5C636-1D7D-428D-A0D2-5032A80DA48C

Q34547322-C6D60689-249B-4000-BBF2-2275335A9E47

Q34547322-DE3BAE84-F682-4A09-B686-65AA9BDEDF68

Q34547322-E0D631C3-0F04-43FA-A62C-9C7EE9EF2DD9

Q34547322-FA130A9E-0604-4E8E-9425-A29429DDF53F

P2860

Q34547322-22F1158A-9498-4A58-848F-3EF121A85F6A

Q34547322-28171F04-1088-4851-82D0-55F785ECBF72

Q34547322-40408C92-C278-4CEA-8994-5E6C6C39C350

Q34547322-55B0B3B2-8DCA-47E1-99CA-7188D39FDB05

Q34547322-5C3C5E4A-9332-4CCB-867D-9260E20A5052

Q34547322-72B6AA09-A6FD-4411-A4D1-770B8E2B80DB

Q34547322-8EA571E0-6793-4C38-B005-D362FC612C95

Q34547322-987A0160-DD92-47DB-94CB-AC1B23FCC055

Q34547322-9EF4A367-661E-4B49-AE30-18131815E9A1

Q34547322-AADAD36E-A338-4290-81FE-FD9691DF25AB

P304

Q34547322-CFA9B7C5-640B-4262-A62B-AF1BE0D1E9EB

P31

Q34547322-430F42F7-93FE-439C-8FCD-364F44B087FE

P356

Q34547322-896D9ED9-E5A5-4613-8C82-576B9E2109BD

P407

Q34547322-1CF393C6-344A-4120-BDBB-C658EC4A1BD4

P433

Q34547322-833A9FA2-B361-43C3-84F1-2859CE9289AF

P478

Q34547322-5CF009BC-4B23-4573-B214-A33DF2FAAEAA

P577

Q34547322-6A765896-98B4-4BF8-AD3C-4389CCEEC32F

P698

Q34547322-3AEC5203-F857-4EAE-8CD1-ABBAFB534634

P932

Q34547322-11A2A188-6A75-43EC-A1E5-8D1DEA29BE96

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Didanosine pharmacokinetics in ...... on: influence of hemodialysis.

@en

P2093

Borsa Lebas F

http://www.w3.org/2001/XMLSchema#string

Chauveau P

http://www.w3.org/2001/XMLSchema#string

Mignon F

http://www.w3.org/2001/XMLSchema#string

Parent de Curzon O

http://www.w3.org/2001/XMLSchema#string

Poignet JL

http://www.w3.org/2001/XMLSchema#string

Singlas E

http://www.w3.org/2001/XMLSchema#string

Sobel A

http://www.w3.org/2001/XMLSchema#string

Taburet AM

http://www.w3.org/2001/XMLSchema#string

Viron B

http://www.w3.org/2001/XMLSchema#string

al Khayat R

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.

Drug dosage in renal disease.

In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine.

Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivity.

Plasma protein binding and distribution characteristics of drugs as indices of their hemodialyzability.

Pharmacokinetics of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in patients with severe human immunodeficiency virus infection.

Pharmacokinetics of 2',3'-dideoxyinosine in patients with severe human immunodeficiency infection. II. The effects of different oral formulations and the presence of other medications.

The assessment of fractional drug removal by extracorporeal dialysis.

Statistical moments in pharmacokinetics.

P304

1519-1524

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.36.7.1519

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

1992-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1510449

http://www.w3.org/2001/XMLSchema#string

P932

191614

http://www.w3.org/2001/XMLSchema#string